The new treatment guidelines published today in Gastroenterology describe a personalized approach to treating patients with approved pharmacological treatments for irritable bowel syndrome (IBS) with constipation (IBS-C) or IBS with diarrhea (IBS-D). IBS is one of the most common disorders of both intestines, affecting up to 35 million Americans.
The guidelines state, for the first time, when to use newly introduced IBS medications, when to rely on old FDA-approved medications, and when to use over-the-counter medications. With more treatments available, doctors can tailor a personalized approach based on the symptoms a patient with IBS is experiencing.
We have so many treatment options, we can now take a treatment approach aimed at the patient’s symptoms. It is very important for patients to be open about their IBS symptoms and just as important for gastroenterologists to set realistic expectations for this chronic disease to ensure the best quality of life for their patients with IBS. “
Shahnaz Sultan, MD, author, AGAF
Tips for patients with IBS: Prioritize lifestyle changes (including exercise, sleep, stress reduction), and dietary changes (such as increased fiber or low-carb diet). FODMAP) before seeking an IBS specialist, such as a gastroenterologist, for advanced treatment options. When talking to a provider, be clear about your symptoms to help your doctor determine the right medicine for you.
Read the AGA Clinical Guidelines for the Management of Constipated Irritable Bowel Syndrome (IBS-C) and Irritable Bowel Syndrome with Diarrhea (IBS-D) for a review of both sets of recommendations detailing patient-specific scenarios and the best treatment options.
Source:
American Gastroenterology Association
Magazine reference:
Chang, L., et al. (2022) AGA Clinical Guidelines for the Management of Constipated Irritable Bowel Syndrome (IBS-C). Gastroenterology. doi.org/10.1053/j.gastro.2022.04.016.